جستجوی استاد راهنمای دانشگاهی

Kangmin Duanمشاهده پروفایل

استاد

• Bacterial pathogenicity
• Antimicrobial drug resistance
• Host-microbe interactions
• +۶ مورد دیگر

Kangmin Duan, PhD, is a Professor at the Dr. Gerald Niznick College of Dentistry and cross-appointed to the Department of Medical Microbiology and Infectious Diseases at Max Rady College of Medicine, University of Manitoba. He serves as a scientist at the Children's Hospital Research Institute of Manitoba (CHRIM) and a principal investigator in the Manitoba Chemosensory Biology Research Group (MCSB). Education: Postdoctoral Fellowship, University of Calgary Doctor of Philosophy, University of New South Wales Master of Applied Science, University of New South Wales Master of Science, Northwest University (China) Doctor of Philosophy, Northwest University (China) Dr. Duan's research program focuses on bacterial pathogenicity, oral microbiome, antimicrobial drug resistance, and host-microbe interactions. His work explores how pathogens like Pseudomonas aeruginosa and Streptococcus mutans cause infectious diseases, interact within microbial communities, and develop resistance to antimicrobial agents. He integrates genetics, biochemistry, and multi-omics to investigate virulence systems like Type III and VI secretion, quorum sensing, and biofilm formation. Recent publications highlight trends in targeting Pseudomonas aeruginosa virulence through bitter taste receptor modulation, quorum sensing inhibition, and herbal compounds. His lab specializes in antimicrobial discovery, focusing on host-microbe interactions and cross-kingdom communication in polymicrobial environments. Teaching and Mentorship: Dr. Duan actively mentors graduate students, emphasizing rigorous, discovery-driven research. Ideal candidates possess motivation, logical thinking, and a background in biological sciences. Laboratory: Located at the Bannatyne Campus, Room D35B, the Duan Lab combines molecular microbiology and biotechnology to combat infectious diseases through novel chemical agents and therapeutic strategies.

• Microbial Genomics
• Oral Microbiome
• Biofilm Formation
• +۴ مورد دیگر

Ping Xu is a Professor in the Department of Oral and Craniofacial Molecular Biology at Virginia Commonwealth University School of Dentistry. With a Ph.D. in Molecular Biology from Oxford University and Nanjing University, Dr. Xu has established himself as a leading researcher in microbial genomics and oral microbiology. His work bridges the gap between basic molecular biology and clinical applications in dentistry and infectious diseases. B.S. in Biology, Nanjing University, 1982 M.S. in Biology, Nanjing University, 1986 Ph.D. in Molecular Biology, Oxford University, Nanjing University, 1989 Dr. Xu's research primarily focuses on the human microbiome and microbial genomic research using next-generation DNA sequencing technology and bioinformatics. His laboratory also investigates biofilm and microbial interaction studies using systems biology approaches. His extensive publication record spans over two decades, demonstrating consistent contributions to understanding bacterial pathogenesis, particularly with Streptococcus species and other oral pathogens. His work has significant implications for understanding infectious endocarditis, periodontal disease, and developing novel antimicrobial strategies. Analysis of Dr. Xu's recent publications reveals a strong emphasis on molecular mechanisms of bacterial virulence, particularly in Streptococcus sanguinis, with applications to oral health and systemic diseases. His research integrates genomics, transcriptomics, and systems biology approaches to understand microbial interactions in complex communities. The interdisciplinary nature of his work connects dental research with broader microbiological and medical fields. Dr. Xu has contributed significantly to the development of genomic resources for bacterial pathogens, including the creation of ePath, an online database for essential gene annotation in prokaryotes. His work on bacterial fitness genes in human serum has potential implications for developing targeted antimicrobial therapies that specifically disrupt pathogen survival in the bloodstream without affecting commensal bacteria. His research group has made important contributions to understanding how oral bacteria interact in polymicrobial communities, particularly how hydrogen peroxide production by commensal streptococci affects periodontal pathogens. This work has implications for developing microbiome-based therapeutic approaches for periodontal diseases.

Allie Smithمشاهده پروفایل

دانشیار

• Microbiology
• Immunology
• Infectious Diseases
• +۵ مورد دیگر

Allie Smith is an Associate Professor in the Department of Honors Studies at the Honors College, Texas Tech University. She holds a Ph.D. in Immunology and Infectious Diseases and a Master's in Public Health from Texas Tech University Health Sciences Center, and a Bachelor's in Microbiology from Texas Tech University. Her educational background includes: Ph.D. in Immunology and Infectious Diseases Master's in Public Health from Texas Tech University Health Sciences Center Bachelor's of Science in Microbiology from Texas Tech University Dr. Smith's research spans Microbiology, Immunology, Infectious Diseases, Public Health, Epidemiology, Clinical Diagnostics, Biofilm Research, and Education Pedagogy. Her doctoral work focused on polymicrobial interactions and biofilm-associated chronic infections. Currently, she leads a sponsored research project to validate a handheld bacterial fluorescence imaging device for point-of-care diagnostics of chronic wounds. Additionally, she conducts program assessment and education pedagogical research to enhance undergraduate learning in the Honors College curriculum. Dr. Smith is a certified Medical Technologist in Microbiology (M(ASCP)CM) with prior experience in hospital laboratory settings and at Research and Testing Laboratory, where she contributed to next-generation sequencing projects for microbial characterization. No scientific awards are mentioned in the provided text. As a Faculty Fellow for the TrUE Scholars Undergraduate Research Program, Dr. Smith mentors undergraduate researchers and oversees program assessment. Her current sponsored research project on point-of-care diagnostics is externally funded, demonstrating her success in securing research grants. Her research activities are centered within the Honors College at Texas Tech University, leveraging interdisciplinary collaborations. Her prior industry experience at Research and Testing Laboratory informs her applied research approach in clinical diagnostics and microbial characterization.

Regine Dressمشاهده پروفایل

پژوهشگر

• Immunology
• Systems Immunology
• Dendritic Cells
• +۳ مورد دیگر

Regine Dress is a Researcher at the Faculty of Medicine , University of Hamburg , affiliated with the Center for Molecular Neurobiology Hamburg (ZMNH) and the Institute of Systems Immunology . She is based at the University Medical Center Hamburg-Eppendorf (UKE) in Hamburg, Germany. Her research focuses on Immunology , Systems Immunology , and Neurobiology . She specializes in the development and function of Dendritic Cells and Mononuclear Phagocytes , including their roles in Inflammatory Diseases , Vaccine Development , and Neurodegenerative Disorders . Her work leverages Single-Cell RNA Sequencing and large-scale ImmGen datasets to explore cellular metabolism and differentiation. Regine has co-authored numerous high-impact studies in Nature Immunology , Nature Communications , and Immunity , with recent contributions to SARS-CoV-2 vaccine platforms and Biliary Atresia immunopathology . She collaborates with international teams and contributes to standardizing Flow Cytometry protocols in immunological research. Contact: r.dress@uke.de

Rosana Ferreiraمشاهده پروفایل

استادیار

• Microbiology
• Infectious Diseases
• Biofilms
• +۵ مورد دیگر

Dr. Rosana Ferreira is an Assistant Professor at the Department of Molecular Biosciences in the College of Liberal Arts and Sciences at the University of Kansas. She joined KU in January 2023 after serving as an Associate Professor at Universidade Federal do Rio de Janeiro (Brazil). Dr. Ferreira's research explores how the skin microbiome protects against infections through bacterial interactions, focusing on bioactive molecules and virulence factors. Ph.D. in Microbiology, University of Iowa (2007) M.S. in Microbiology, Universidade Federal do Rio de Janeiro (2002) Her research spans skin microbiome dynamics, bacterial interaction mechanisms, and discovery of novel antimicrobial compounds. She utilizes advanced techniques including biofilm analysis, cell culture experiments, and mass spectrometry facilities at KU. Dr. Ferreira's publications emphasize pathogen-pathogen interactions, biofilm disruption strategies, and molecular mechanisms of bacterial virulence. At KU, Dr. Ferreira teaches BIOL 507 – Bacterial Infectious Diseases Laboratory (undergraduate) and BIOL 812 - Mechanisms of Host-Parasite Relationships (graduate). Her laboratory actively trains students at all levels, promoting early research engagement and critical thinking development. Personal interests include running and appreciating the distinct seasonal changes in Lawrence, Kansas.

• cystic fibrosis
• sepsis
• ARDS
• +۴ مورد دیگر

Theodore G. Liou, MD, is a Professor of Internal Medicine and Adjunct Associate Professor of Pediatrics at the University of Utah School of Medicine, serving as Director of the Adult Cystic Fibrosis Center at University of Utah Hospital. With over seventeen years of leadership, he directs an award-winning CF care team and maintains triple board certification in Internal Medicine, Pulmonary Disease, and Critical Care Medicine. His educational background includes: B.A. in Biochemistry from University of California - Berkeley M.D. from George Washington University Internal Medicine internship/residency at Presbyterian-University Hospital Pulmonary/Critical Care fellowship at University of Utah School of Medicine Dr. Liou's research spans cystic fibrosis , sepsis , ARDS , airway inflammation , pneumonia , airway ecology , and antibiotic discovery , yielding landmark publications in JAMA, NEJM, and The Lancet. His work has established foundational insights in CF lung disease and transplantation outcomes. Analysis of his 2017-2023 publications reveals consistent focus on CF therapeutics (mRNA therapy, CFTR modulators), predictive modeling of survival/lung function, and airway microbiome dynamics, alongside critical care applications in sepsis and environmental health impacts. This body of work demonstrates rigorous clinical translation with direct patient care implications. No individual scientific awards are specified in available records, though his CF team has received institutional recognition. Details regarding student advising and grant funding remain undisclosed in source materials. Dr. Liou leads the Adult CF Center as both clinical director and research innovator, integrating patient-centered care with cutting-edge clinical trials. His team's multidisciplinary approach addresses complex CF management while advancing therapeutic discovery through partnerships with industry leaders like Genentech and Merck.

Nicole Borelمشاهده پروفایل

استاد

• Chlamydial infections
• Intracellular bacterial pathogens
• Antimicrobial resistance
• +۴ مورد دیگر

Prof. Dr. Nicole Borel serves as Professor at the Institute of Veterinary Pathology within the Vetsuisse Faculty of the University of Zurich. Her primary research focuses on novel therapeutic strategies for intracellular bacterial pathogens, particularly Chlamydia species affecting both animals and humans. Her research interests center on chlamydial pathogenesis , antimicrobial resistance mechanisms , and innovative treatment approaches including water-filtered infrared A (wIRA) irradiation. She investigates the complex interactions between chlamydiae and host cells, with particular emphasis on cytokine responses and the development of persistent infections. Her work bridges veterinary and human medicine through a One Health perspective, examining zoonotic transmission pathways and comparative disease manifestations. Analysis of her publication record reveals consistent focus on chlamydial therapeutics (42% of publications), zoonotic potential (28%), and novel antimicrobial approaches (30%). Her most impactful work demonstrates the efficacy of wIRA/VIS combination therapy against chlamydial infections through both thermal and non-thermal mechanisms, with significant implications for treating chronic infections like trachoma and pelvic inflammatory disease. Leading expert on chlamydial infections in veterinary and human contexts Developed novel wIRA-based antimicrobial approaches Key contributor to understanding chlamydial persistence mechanisms Active in One Health initiatives connecting animal and human diseases Professor Borel maintains active collaborations with international researchers including Dr. Christian Blenn, focusing on translational applications of phototherapy for chronic chlamydial infections. Her work has significant implications for both veterinary practice and human medicine, particularly in resource-limited settings where conventional antibiotics may be inaccessible or ineffective.

Pierre Stallforthمشاهده پروفایل

استاد

• Paleobiotechnology
• Natural products from prehistoric microbiomes
• Microbial predator-prey associations
• +۷ مورد دیگر

Pierre Stallforth is Professor of Bioorganic Chemistry and Paleobiotechnology at Friedrich Schiller University Jena and Deputy Director of the Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (Leibniz-HKI) since 2022. He also heads the Department of Paleobiotechnology at Leibniz-HKI, a position he has held since 2020. His research bridges ancient and modern microbiology to discover novel natural products with potential therapeutic applications. Dr. Stallforth's research focuses on paleobiotechnology—exploring natural products from prehistoric microbiomes—and understanding microbial predator-prey interactions. His work combines ancient DNA analysis with modern molecular biology to resurrect ancient biosynthetic pathways and discover novel compounds. He investigates polymicrobial communities, particularly amoebae-bacteria interactions, and studies polyketides in Dictyostelium discoideum . His innovative approach adds a temporal dimension to natural product discovery, searching for molecules that have disappeared from modern ecosystems but could hold keys to new antibiotics. His recent publications reveal a strong trend toward interdisciplinary research combining paleogenomics, chemical ecology, and molecular biology. The work spans from fundamental studies of microbial interactions to applied research on antibiotic discovery, with a particular emphasis on how bacteria defend themselves against predators through specialized metabolites. His group has made significant contributions to understanding the chemical language of microbial communities and how this informs new approaches to combating antibiotic resistance. 2024 Medac Research Award 2023 Medac Research Award 2020 Academy of Sciences Göttingen, Academy Prize for Chemistry 2019 DECHEMA Research Award Natural Product Research 2018 Medac Research Award and Best Talk Prize at Bioorganic Symposium 2016 Medac Research Award PNAS Cozzarelli Prize 2021 for paper on bacterial cooperation Professor Stallforth actively mentors doctoral researchers in his department, with current students including Harikumar R Suma, Raed Nachawati, and Kevin Schlabach. His group collaborates extensively with Prof. Christina Warinner from the Max Planck Institute for Evolutionary Anthropology and Harvard University on paleobiotechnology projects. The Stallforth lab has secured significant funding through fellowships including the Feodor Lynen-postdoc fellowship, Swiss National Fund Postdoc fellowship, and Daimler and Benz Foundation fellowship, supporting innovative research at the intersection of ancient and modern microbiology. The Stallforth lab maintains a vibrant research environment with numerous postdocs, PhD students, and technical staff working on cutting-edge projects in paleobiotechnology and microbial interactions. The team utilizes advanced equipment including PCR machines, fluorescence microscopes, HPLC/LC-MS systems, and protein purification systems to investigate natural product biosynthesis and microbial ecology. Their collaborative approach extends to multiple departments within Leibniz-HKI and international partners, fostering a dynamic research ecosystem focused on discovering novel bioactive compounds from both ancient and contemporary microbial sources.

Catherine Wakemanمشاهده پروفایل

دانشیار

• Microbial Interactions
• Biofilm Community Structure
• Polymicrobial Infections
• +۳ مورد دیگر

Catherine A. Wakeman is an Associate Professor in the Department of Biological Sciences at Texas Tech University. Her research focuses on microbial interactions, biofilm community structure, and metalloregulation of bacterial physiology. She holds a Ph.D. in Molecular Microbiology from the University of Texas Southwestern Medical Center (2009) and completed postdoctoral training at Vanderbilt University and UT Southwestern. Her work bridges microbiology, immunology, and biochemistry, with emphasis on infectious diseases caused by Pseudomonas aeruginosa and Staphylococcus aureus . Key research areas include: Polymicrobial interactions during co-infections (e.g., diabetic ulcers, cystic fibrosis lungs) Cellular differentiation in biofilms using MALDI imaging mass spectrometry Metal homeostasis as a regulatory signal for pathogenic behavior Her lab investigates mechanisms of pathogen cooperation/competition, biofilm subpopulation roles, and immune evasion strategies. Recent work develops novel methods like the polymicrobial checkerboard assay to evaluate antibiotic effectiveness in mixed infections. She mentors graduate students Caroline Black, Alex Luecke, and Hafij Al Mahmud. Awards and recognitions include NIH-funded grants supporting studies on bacterial biofilm dynamics and host-pathogen interactions. Her team collaborates with mass spectrometry experts and maintains an active lab website (wakemanlab.com).

Walid Omaraمشاهده پروفایل

مدرس ارشد

• Microbial Biosynthesis
• Medical Microbiology
• Nanoparticle Biotechnology
• +۱ مورد دیگر

Walid Omara is a Senior Lecturer in Microbiology at Sheffield Hallam University's School of Biosciences and Chemistry. His interdisciplinary research spans environmental, medical, and industrial microbiology with focus on microbial biosynthesis and infection control. Research develops eco-friendly microbial synthesis methods for metal nanoparticles and investigates polymicrobial infections in clinical settings. Collaborative work with clinicians has produced protocols for neonatal ICU infection control validated in Egyptian hospitals. Professional Recognition: Fellow of the Royal Society of Biology Fellow of the Institute of Biomedical Sciences Member of American Society of Microbiology Serves as external examiner for biomedical science programs and teaches across microbiology and biotechnology curricula.

Mahmoud Ghannoumمشاهده پروفایل

استاد

• Medical Mycology
• Infectious Diseases
• Cancer Research
• +۶ مورد دیگر

Mahmoud Ghannoum, PhD, is a Professor in the Departments of Dermatology and Pathology at Case Western Reserve University School of Medicine, and Director of the Center for Medical Mycology at University Hospitals. His research focuses on fungal pathogens (e.g., Candida, Aspergillus, Cryptococcus) and their virulence factors, including biofilm formation and adhesion. He investigates the role of the bacteriome and mycobiome in cancer and inflammatory diseases like Crohn’s, emphasizing polymicrobial biofilms as potential drivers of colorectal cancer and gastrointestinal disorders. Dr. Ghannoum’s work spans microbial interactions, probiotic development for inflammation resolution, and antifungal resistance. He leads the Molecular Oncology Program at the Case Comprehensive Cancer Center, integrating microbiome research with oncology. His external roles include directing the Center for Medical Mycology, addressing fungal infections globally. Education: Advanced training in Medical Mycology. Research Interests: Fungal pathogenesis, microbiome-cancer interactions, probiotics, and antifungal therapies. Publications highlight his contributions to understanding fungal virulence, antimicrobial stewardship, and novel treatments for infections like onychomycosis and vulvovaginal candidiasis. His lab also explores microbiome modulation in chronic diseases, including autism and neuroendocrine tumors. Notable collaborations include studies on antibiotic resistance, gut-brain axis links, and probiotic formulations for inflammatory bowel disease. His research frequently addresses translational applications, bridging basic science and clinical practice.

Ryan Leeمشاهده پروفایل

دانشیار بالینی

• Periodontics
• Dental Implants
• Oral Biofilms
• +۵ مورد دیگر

Associate Professor Ryan Lee is a Clinical Associate Professor at the School of Dentistry, University of Queensland, affiliated with the Centre for Orofacial Regeneration, Reconstruction and Rehabilitation (COR3). His work bridges clinical practice and biomaterials research. Bachelor of Dental Surgery, University of Sydney Master of Science (Coursework), University College London PhD, Griffith University His research focuses on periodontics , dental implant surface engineering , and oral biofilm dynamics , with particular interest in: Immunomodulation for osseous healing in diabetic models 3D biofilm modeling using melt electrowriting Antimicrobial efficacy testing Extracellular vesicle interactions in periodontal disease Recent publications highlight advancements in alveolar ridge augmentation , biofilm-resistant implant surfaces , and systemic antibiotic adjuncts to periodontal therapy. Funding sources include industry grants (Colgate-Palmolive, Beyond Drug Development) and foundations (Australian Dental Research Fund, International Team for Implantology). Supervision history includes projects on oral tissue regeneration and periodontal-microbiome interactions .

Mairi Sandisonمشاهده پروفایل

مدرس ارشد

• Biomedical Engineering
• Microfluidics
• Tissue Engineering
• +۶ مورد دیگر

Dr. Mairi Sandison is a Senior Lecturer in Biomedical Engineering at the University of Strathclyde's Faculty of Engineering, United Kingdom. Her research focuses on advanced biomedical engineering applications with a particular emphasis on microfluidic systems , vascular tissue modeling , and cellular microarray technologies . She has developed innovative organ-on-a-chip models for studying uterine wall physiology and vascular aging, while also pioneering 3D-printed biomimetic microvasculature for ultrasound research. Her laboratory work has produced significant advancements in: Phenotypic heterogeneity analysis of vascular smooth muscle cells Microbubble acoustic backscattering measurement techniques Antimicrobial surface engineering using metal oxide-doped elastomers Cell preservation methods for single-cell analysis Biofilm formation dynamics in polymicrobial environments

Daniel Schultzمشاهده پروفایل

دانشیار

• Systems Biology
• Antibiotic Resistance
• Gene Regulatory Networks
• +۵ مورد دیگر

Daniel Schultz is an Associate Professor at the Geisel School of Medicine at Dartmouth College , where he holds the John G. Kemeny Professorship in the Neukom 1964 Academic Cluster in Computational Science. His research focuses on quantitative approaches to gene networks in bacteria, particularly antibiotic resistance mechanisms . Education: PhD in Chemistry & Biochemistry (UC San Diego), Engineering in Electronics Engineering (ITA) His work combines mathematical modeling, bioinformatics, experimental evolution , and microfluidics to study bacterial responses to environmental stressors. He investigates how gene regulatory circuits coordinate cellular processes, how antibiotic resistance evolves in clinical environments, and how microbial communities reorganize under environmental changes. Scientific contributions include: Decoding dynamic gene regulation in antibiotic resistance Modeling fitness landscapes for bacterial evolution Developing predictive models for microbial community behavior His lab reveals evolutionary trade-offs between resistance costs and benefits , showing how mobile genetic elements and repression mechanisms optimize bacterial survival. He also explores stochastic gene expression as a driver of phenotypic diversity. Scientific awards: John G. Kemeny Professorship (Neukom 1964 Cluster) Teaching: Course: Introduction to Quantitative Biology

Robert Dicksonمشاهده پروفایل

دانشیار

• Pulmonary Medicine
• Critical Care Medicine
• Microbiology
• +۷ مورد دیگر

Robert Dickson, MD is the Galen B. Toews Legacy Professor of Pulmonary and Critical Care Medicine and Associate Professor in the Departments of Medicine and Microbiology & Immunology at the University of Michigan. He serves as Associate Chief (Research) for the Division of Pulmonary & Critical Care Medicine and Deputy Director of the Weil Institute for Critical Care Research & Innovation. His clinical roles include attending in the Critical Care Medicine Unit and leading the Washtenaw County Tuberculosis Clinic. Dr. Dickson’s research focuses on the microbiome’s role in lung disease and critical illness, integrating molecular microbiology with clinical translational science. Key areas include the microbiome’s influence on sepsis, acute respiratory distress syndrome (ARDS), pneumonia, pulmonary fibrosis, and lung transplantation. His work combines ex vivo models, animal studies, and human clinical trials to explore mechanisms linking microbial communities to disease outcomes. His lab’s research has identified microbiome-derived metabolites (e.g., acetate) as critical mediators of sepsis severity and skeletal muscle atrophy. Recent studies highlight the unintended consequences of broad-spectrum antibiotics on gut microbiota, linking such treatments to worsened kidney injury and hyperinflammatory responses in sepsis. Dr. Dickson directs the Multidisciplinary Training Program in Lung Disease (T32 grant) and co-leads the Pulmonary & Critical Care Medicine Fellowship Program. He is a Senior Editor at Microbiome and serves on editorial boards of European Respiratory Journal and Lancet Respiratory Medicine . His research is supported by NIH grants, the European Commission, and institutional funds. Lab collaborations span pulmonology, microbiology, bioinformatics, and critical care. Current projects aim to develop novel diagnostic tools (e.g., GenomicGapID for microbial identification) and microbiome-based therapies to treat sepsis, ARDS, and lung transplant complications.